The erythropoietic response to erythropoietin in patients with rheumatoid arthritis

Journal of Laboratory and Clinical Medicine

Volumn 130, Issue 4, 1997, Pages 381-386

  Goodnough, Lawrence Tim ^a   Marcus, Randall E ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031258491     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90037-8     Document Type: Article

References (28)

1. Fischl M, Galpin JE, Levine JD, et al. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 1990;322:1488.
2. Henry DH, Beall GN, Benson GN, et al. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infections and zidovudine therapy. Overview of four clinical trials. Ann Intern Med 1992;117:739-48.
3. Pincus T, Olsen NJ, Russell J, et al. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med 1990;89:161-8.
4. Spivak SL, Barnes DC, Fuchs E, Quinn TC. Serum immunoreactive erythropoietin in HIV-infected patients. JAMA 1989;261:3104-7.
5. Miller CB, Jones RJ, Piantadosi S, Abelloff MD, Spivak JL. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 1990;322:1689-92.
6. Baer AN, Dessypris EN, Goldwasser E, Krantz SB. Blunted erythropoietin response to anemia in rheumatoid arthritis. Br J Haematol 1987;66:559-64.
7. Hochberg MC, Arnold CM, Hogans BB, Spivak JL. Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia. Arthritis Rheum 1988;31:1318-21.
8. Means RT, Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992;80: 1639-47.
9. Goodnough LT, Rudnick S, Price TH, et al. Increased collection of autologous blood preoperatively with recombinant human erythropoietin therapy. N Engl J Med 1989;321: 1163-7.
10. Goodnough LT, Price TH, Rudnick S. Preoperative red blood cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy. Transfusion 1992;32:441-5.
11. Goodnough LT, Price TH, Friedman KD, et al. A phase III trial of recominant human erythropoietin therapy in nonanemic orthpaedic patients subjected to aggressive autologous blood phlebotomy: dose, response, toxicity, and efficacy. Transfusion 1994;34:66-71.
12. Price TH, Goodnough LT, Vogler WR, et al. The effect of recombinant human erythropoieitn on the efficacy of autologous blood donation in patients with low hematocrits. Transfusion 1996;36:29-36.
13. Holland PV, Schmidt PH, editors. Standards for blood banks and transfusion services. 14th ed. Arlington, VA: American Association of Blood Banks, 1991:40.
14. Miale JB. Laboratory medicine hematology. St. Louis: CV Mosby, 1982:360-6.
15. Chaplin H, Mollison PI, Vetter H. The body/venous hematocrit ratio: its consistency over a wide range. J Clin Invest 1953;32:1309.
16. Goodnough LT, Johnston MFM, Toy PTCY, et al. The variability of transfusions practice in primary, elective coronary artery bypass graft surgery. JAMA 1991;265:86-90.
17. Goodnough LT, Bravo J, Hsueh Y, Keating L, Brittenham GM. Red blood cell volume in autologous and homologous blood units: implications for risk/benefit assessment for autologous blood "crossover" and directed blood transfusion. Transfusion 1989;29:821-2.
18. Cook JD, Skikne BS, Lunch SR, Reysser ME. Estimates of iron sufficiency in the US population. Blood 1986;68:726-31.
19. Surgenor DM. The patient's blood is the safest blood. N Engl J Med 1987;316:542-20.
20. Haugen K, Hill E. Large scale autologous blood program in a community hospital. JAMA 1987;257:1211-4.
21. Wasman J, Goodnough LT. Effect of autologous blood donation for elective surgery on physician transfusion behavior: a matched, controlled study. JAMA 1987;258:3135-7.
22. Goodnough LT, Grishaber JE, Birkmeyer JD, Monk TG, Catalona WJ. Efficacy and cost-effectiveness of autologous blood predeposit in patients undergoing radical prostatectomy procedures. Urology 1994;44:226-31.
23. Goodnough LT, Shaffron D, Marcus RE. Impact of preoperative autologous blood donation in elective orthopedic surgery. Vox Sang 1990;59:65-9.
24. Goodnough LT, Brittenham G. Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood predeposit programs. J Lab Clin Med 1990;115:28-35.
25. Goodnough LT, Vizmeg K, Sobecks R, Schwarz A, Soegiarso W. Prevalence and classification of anemia in elective orthopedic surgery patients: implications for blood conservation programs. Vox Sang 1992;63:90-5.
26. Salvarani C, Lasagni D, Casli B, et al. Recombinant human erythropoietin therapy in patients with rheumatoid arthritis with the anemia of chronic disease. J Rheum 1991;18:1168-71.
27. Gudbjornsson B, Hallgren R, Wide L, Birgegard G. Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombinant human erythropoietin. Ann Rheum Dis 1992;51:747-52.
28. Goodnough LT, Monk TG, Brecher ME. Autologous blood procurement in the surgical setting: lessons to be learned in the last 20 years. Vox Sang 1996;71:133-41.